Immunitybio Inc (IBRX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $9.55
• Market Cap: $9.40B
• EPS: $-0.41
• 52-Week High: $12.43
• 52-Week Low: $1.83

Market Sentiment

Immunitybio Inc currently has a Bullish sentiment score of 0.34.

About Immunitybio Inc

ImmunityBio, Inc. is a pioneering immunotherapy company focused on developing innovative treatments utilizing memory T-cells to combat a wide range of cancer types. The company's proprietary cancer vaccine aims to create an effective therapeutic approach that minimizes the reliance on high-dose chemotherapy while enhancing the body's immune response against tumors. By leveraging advanced biotechnology, ImmunityBio strives to transform cancer treatment and improve patient outcomes, positioning...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Immunitybio Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does IBRX pay dividends?

Immunitybio Inc (IBRX) does not currently pay a regular dividend.

What is IBRX's market cap?

Immunitybio Inc (IBRX) has a market capitalization of $9.40B with a current stock price of $9.55.